P3 Health Partners Inc. Class A (PIII)

P3 Health Partners' stock has experienced significant volatility and decline. As of March 31, 2026, the share price was $3.08, a 66.43% decrease from April 1, 2025. Key events include the Q4 and full-year 2025 earnings release, which reported a net loss of $323.1 million, leading to a stock decrease. The Q3 2025 earnings release reported a revenue decrease of 5%. P3 expanded through a joint venture with Commonwealth Primary Care ACO. The company's auditor issued a going concern doubt in the 2025 10-K filing due to limited cash and significant debt.

P3 Health Partners experiences seasonality in medical expenses and membership attribution. Medical expenses vary seasonally due to weather and the prevalence of illnesses like the flu during colder months. New members are typically attributed on January 1st, aligning with the Annual Enrollment Period. Revenue per member generally declines over the year.

P3 Health Partners, Inc. (PIII) is a patient-centered and physician-led population health management company operating in the Healthcare sector. They provide support services to doctors and clinicians, aiming to enhance patient outcomes, increase provider satisfaction, and reduce care costs. P3 primarily generates revenue through capitated arrangements within Medicare Advantage and ACO REACH programs and also operates clinics and wellness centers.

P3 Health Partners operates across Arizona, Nevada, Oregon, and California. As of May 2025, they had a network of over 3,100 affiliated primary care providers, managing patient care across 24 counties in these four states.

P3 Health Partners aims to improve healthcare by focusing on patients and providers through a population health management model. They emphasize patient empowerment and community outreach. However, the company has faced customer complaints regarding billing and insurance coverage, as well as unprofessional staff responses. The company's financial strain and going concern doubt could negatively impact its reputation.

P3 Health Partners Inc. has a diverse ownership structure, including institutional investors, venture capital and private equity firms, and individual insiders. Major institutional owners include Alyeska Investment Group, L.P., Vanguard Group Inc., and BlackRock, Inc. Chicago Pacific Founders Ugp LLC is the largest individual shareholder. As of April 8, 2026, institutional owners held 244,402 shares.